The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow
- PMID: 1633861
- DOI: 10.1016/0014-5793(92)80655-z
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow
Abstract
Small colloidal particulates (150 nm and below, in diameter) can be redirected specifically to the rabbit bone marrow following intravenous administration by coating their surface with the block co-polymer poloxamer-407, a non-ionic surfactant. The coated colloids are sequestered by the sinusoidal endothelial cells of the bone marrow and are accumulated in dense bodies within these cells. The uptake of poloxamer-407-coated colloids by marrow endothelial cells suggests that the steric repulsive barrier, imposed by the polyoxyethylene segment of the polymer, to particle-cell interaction can apparently be overcome by a specific interaction mechanism(s) with the cell surface. Such a dramatic uptake cannot be achieved with other block co-polymers of similar structure to poloxamer-407. The application of the current model for the site-specific targeting of drug carriers to bone marrow and the prevention of the adherence of metastases of tumours which selectively colonize the bone marrow endothelium is discussed.
Similar articles
-
Targeting of colloidal particles to the bone marrow.Life Sci. 1987 Apr 20;40(16):1553-60. doi: 10.1016/0024-3205(87)90120-2. Life Sci. 1987. PMID: 3561165
-
The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338).FEBS Lett. 1984 Feb 13;167(1):79-82. doi: 10.1016/0014-5793(84)80836-4. FEBS Lett. 1984. PMID: 6698206
-
Uptake of carbon and polystyrene particles by the sinusoidal endothelium of rabbit bone marrow and liver and rat bone marrow, with special reference to multiparticle-pinocytosis.Arch Histol Jpn. 1984 Aug;47(3):303-17. doi: 10.1679/aohc.47.303. Arch Histol Jpn. 1984. PMID: 6497593
-
Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow.Crit Rev Ther Drug Carrier Syst. 1990;7(3):187-209. Crit Rev Ther Drug Carrier Syst. 1990. PMID: 2073686 Review.
-
Polymeric microspheres as drug carriers.Biomaterials. 1988 Jan;9(1):111-5. doi: 10.1016/0142-9612(88)90081-6. Biomaterials. 1988. PMID: 3280037 Review.
Cited by
-
Elucidating the Influence of Tumor Presence on the Polymersome Circulation Time in Mice.Pharmaceutics. 2019 May 20;11(5):241. doi: 10.3390/pharmaceutics11050241. Pharmaceutics. 2019. PMID: 31137479 Free PMC article.
-
Preparation of sterically stabilized human serum albumin nanospheres using a novel Dextranox-MPEG crosslinking agent.Pharm Res. 1994 Nov;11(11):1588-92. doi: 10.1023/a:1018957704209. Pharm Res. 1994. PMID: 7532861
-
Strategies in the design of nanoparticles for therapeutic applications.Nat Rev Drug Discov. 2010 Aug;9(8):615-27. doi: 10.1038/nrd2591. Epub 2010 Jul 9. Nat Rev Drug Discov. 2010. PMID: 20616808 Review.
-
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070. Pharmacol Rev. 2016. PMID: 27363439 Free PMC article. Review.
-
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.Biomaterials. 2007 Feb;28(5):869-76. doi: 10.1016/j.biomaterials.2006.09.047. Epub 2006 Oct 20. Biomaterials. 2007. PMID: 17055572 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources